v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Unearned ESOP Shares
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   11,208,500        
Beginning balance at Dec. 31, 2023 $ 134,859,576 $ 112,085 $ 101,347,566 $ 87,902,747 $ (11,457,726) $ (43,045,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 9,377,348     9,377,348    
Other comprehensive (loss) income, net of tax (benefit) expense (2,761,101)         (2,761,101)
ESOP shares earned 660,972   (74,344)   735,316  
Forfeiture of restricted stock awards (in shares)   (400)        
Forfeiture of restricted stock awards 0 $ (4) 4      
Stock based compensation 1,474,062   1,474,062      
Exercise of stock options (in shares) [1]   1,952        
Exercise of stock options [1] (12) $ 20 (32)      
Common stock dividends ($0.60 per share) (5,697,109)     (5,697,109)    
Repurchase of common stock (in shares)   (395,092)        
Repurchase of common stock $ (5,041,976) $ (3,951) (5,038,025)      
Ending balance (in shares) at Dec. 31, 2024 10,814,960 10,814,960        
Ending balance at Dec. 31, 2024 $ 132,871,760 $ 108,150 97,709,231 91,582,986 (10,722,410) (45,806,197)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 11,576,767     11,576,767    
Other comprehensive (loss) income, net of tax (benefit) expense 11,247,512         11,247,512
ESOP shares earned 738,051   2,734   735,317  
Granting of restricted stock awards (in shares)   88,379        
Granting of restricted stock awards 0 $ 884 (884)      
Stock based compensation $ 815,821   815,821      
Exercise of stock options (in shares) 108,213 23,744 [1]        
Exercise of stock options [1] $ (4) $ 237 (241)      
Common stock dividends ($0.60 per share) (5,835,148)     (5,835,148)    
Repurchase of common stock (in shares)   (425,823)        
Repurchase of common stock $ (5,633,659) $ (4,258) (5,629,401)      
Ending balance (in shares) at Dec. 31, 2025 10,501,260 10,501,260        
Ending balance at Dec. 31, 2025 $ 145,781,100 $ 105,013 $ 92,897,260 $ 97,324,605 $ (9,987,093) $ (34,558,685)
[1] 1) The amount shown represents the number of shares issued in net-settled option transactions where some shares are netted from a portion of the exercises.